OBJECTIVE Acute hyperglycemia is a powerful predictor of poor prognosis in acute myocardial infarction (AMI), particularly in patients without diabetes. This emphasizes the importance of an acute glycemic rise rather than glycemia level at admission alone.We investigated in AMI whether the combined evaluation of acute and chronic glycemic levels, as compared with admission glycemia alone, may have a better prognostic value. RESEARCH DESIGN AND METHODS We prospectively measured admission glycemia and estimated average chronic glucose levels (mg/dL) by the following formula: [(28.7×glycosylated hemoglobin %)-46.7], and calculated the acute-to-chronic (A/C) glycemic ratio in 1,553 consecutive AMI patients (mean±SD age 67±13 years). The primary end pointwas the combination of in-hospital mortality, acute pulmonary edema, and cardiogenic shock. RESULTS The primary end point rate increased in parallel with A/C glycemic ratio tertiles (5%, 8%, and 20%, respectively; P for trend <0.0001). A parallel increase was observed in troponin I peak value (15 ± 34 ng/mL, 34 ± 6± ng/mL, and 68 ± 131 ng/mL; P < 0.0001). At multivariable analysis, A/C glycemic ratio remained an independent predictor of the primary end point and of troponin I peak value, even after adjustment for major confounders. At reclassification analyses, A/C glycemic ratio showed the best prognostic power in predicting the primary end point as compared with glycemia at admission intheentire population (net reclassification improvement 12%[95%CI 4-20]; P = 0.003) and, particularly, in patients with diabetes (27% [95% CI 14-40]; P<0.0001). CONCLUSIONS In AMI patients with diabetes, A/C glycemic ratio is a better predictor of in-hospital morbidity and mortality than glycemia at admission.

Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction : a prospective study / G. Marenzi, N. Cosentino, V. Milazzo, M. De Metrio, M. Cecere, S. Mosca, A. Rubino, J. Campodonico, M. Moltrasio, I. Marana, M. Grazi, G. Lauri, A. Bonomi, F. Veglia, R. Manfrini, A.L. Bartorelli. - In: DIABETES CARE. - ISSN 0149-5992. - 41:4(2018 Apr 01), pp. 847-853. [10.2337/dc17-1732]

Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction : a prospective study

N. Cosentino;V. Milazzo;M. De Metrio;F. Veglia;A.L. Bartorelli
2018

Abstract

OBJECTIVE Acute hyperglycemia is a powerful predictor of poor prognosis in acute myocardial infarction (AMI), particularly in patients without diabetes. This emphasizes the importance of an acute glycemic rise rather than glycemia level at admission alone.We investigated in AMI whether the combined evaluation of acute and chronic glycemic levels, as compared with admission glycemia alone, may have a better prognostic value. RESEARCH DESIGN AND METHODS We prospectively measured admission glycemia and estimated average chronic glucose levels (mg/dL) by the following formula: [(28.7×glycosylated hemoglobin %)-46.7], and calculated the acute-to-chronic (A/C) glycemic ratio in 1,553 consecutive AMI patients (mean±SD age 67±13 years). The primary end pointwas the combination of in-hospital mortality, acute pulmonary edema, and cardiogenic shock. RESULTS The primary end point rate increased in parallel with A/C glycemic ratio tertiles (5%, 8%, and 20%, respectively; P for trend <0.0001). A parallel increase was observed in troponin I peak value (15 ± 34 ng/mL, 34 ± 6± ng/mL, and 68 ± 131 ng/mL; P < 0.0001). At multivariable analysis, A/C glycemic ratio remained an independent predictor of the primary end point and of troponin I peak value, even after adjustment for major confounders. At reclassification analyses, A/C glycemic ratio showed the best prognostic power in predicting the primary end point as compared with glycemia at admission intheentire population (net reclassification improvement 12%[95%CI 4-20]; P = 0.003) and, particularly, in patients with diabetes (27% [95% CI 14-40]; P<0.0001). CONCLUSIONS In AMI patients with diabetes, A/C glycemic ratio is a better predictor of in-hospital morbidity and mortality than glycemia at admission.
internal medicine; endocrinology, diabetes and metabolism; advanced and specialized nursing
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
1-apr-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
Prognostic.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 852.96 kB
Formato Adobe PDF
852.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/577142
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 70
  • ???jsp.display-item.citation.isi??? 66
social impact